ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A phase II study in patients with hormone receptor positive breast cancer with bortezomib (Velcade®) in the reversal of endocrine resistance
http://isrctn.org/>
◽
10.1186/isrctn55808957
◽
2012
◽
Author(s):
Luc Dirix
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Hormone Receptor
◽
Phase Ii Study
◽
Endocrine Resistance
◽
Hormone Receptor Positive
◽
Positive Breast Cancer
Download Full-text
Related Documents
Cited By
References
Correction: A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–positive Breast Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-21-0193
◽
2021
◽
Vol 27
(5)
◽
pp. 1582-1582
Author(s):
Sara M. Tolaney
◽
Solmaz Sahebjam
◽
Emilie Le Rhun
◽
Thomas Bachelot
◽
Peter Kabos
◽
...
Keyword(s):
Breast Cancer
◽
Brain Metastases
◽
Phase Ii
◽
Hormone Receptor
◽
Phase Ii Study
◽
Hormone Receptor Positive
◽
Positive Breast Cancer
Download Full-text
Abstract P1-15-01: A randomized phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally-advanced hormone-receptor-positive breast cancer: First results
10.1158/0008-5472.sabcs13-p1-15-01
◽
2013
◽
Author(s):
N Quenel-Tueux
◽
F Dalenc
◽
T Bachelot
◽
M Pulido
◽
H Bonnefoi
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Hormone Receptor
◽
Phase Ii Study
◽
Locally Advanced
◽
Hormone Receptor Positive
◽
Randomized Phase Ii
◽
First Results
◽
Positive Breast Cancer
Download Full-text
Abstract OT1-02-02: A phase II study of pembrolizumab in combination with palliative radiotherapy for metastatic hormone receptor positive breast cancer
10.1158/1538-7445.sabcs17-ot1-02-02
◽
2018
◽
Author(s):
R Barroso-Sousa
◽
H Gao
◽
WT Barry
◽
IE Krop
◽
JD Schoenfeld
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Hormone Receptor
◽
Phase Ii Study
◽
Palliative Radiotherapy
◽
Hormone Receptor Positive
◽
Positive Breast Cancer
Download Full-text
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-20-1764
◽
2020
◽
Vol 26
(20)
◽
pp. 5310-5319
◽
Cited By ~ 3
Author(s):
Sara M. Tolaney
◽
Solmaz Sahebjam
◽
Emilie Le Rhun
◽
Thomas Bachelot
◽
Peter Kabos
◽
...
Keyword(s):
Breast Cancer
◽
Brain Metastases
◽
Phase Ii
◽
Hormone Receptor
◽
Phase Ii Study
◽
Hormone Receptor Positive
◽
Positive Breast Cancer
Download Full-text
A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer
Cancer Medicine
◽
10.1002/cam4.164
◽
2014
◽
Vol 3
(2)
◽
pp. 293-299
◽
Cited By ~ 3
Author(s):
Sara M. Tolaney
◽
Joon Jeong
◽
Hao Guo
◽
Jane Brock
◽
Daniel Morganstern
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Hormone Receptor
◽
Phase Ii Study
◽
Hormone Receptor Positive
◽
Positive Breast Cancer
Download Full-text
Abstract OT3-05-10: A single arm phase II study of palbociclib in combination with tamoxifen as first line therapy for metastatic hormone receptor positive breast cancer
10.1158/1538-7445.sabcs17-ot3-05-10
◽
2018
◽
Author(s):
OC Danciu
◽
K Hoskins
◽
D Tamkus
◽
C Truica
◽
A Blaes
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Hormone Receptor
◽
Phase Ii Study
◽
First Line
◽
First Line Therapy
◽
Hormone Receptor Positive
◽
Line Therapy
◽
Positive Breast Cancer
Download Full-text
Phase II study of Ra-223 combined with hormonal therapy and denosumab for treatment of hormone receptor-positive breast cancer with bone-dominant metastasis.
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.1065
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. 1065-1065
◽
Cited By ~ 2
Author(s):
Naoto T. Ueno
◽
Rie K. Tahara
◽
Babita Saigal
◽
Takeo Fujii
◽
James M. Reuben
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Hormonal Therapy
◽
Hormone Receptor
◽
Phase Ii Study
◽
Hormone Receptor Positive
◽
Positive Breast Cancer
Download Full-text
Abstract P1-16-02: Phase II study of the feasibility and safety of radium-223 dichloride in combination with hormonal therapy and denosumab for the treatment of patients with hormone receptor-positive breast cancer with bone-dominant metastasis
10.1158/1538-7445.sabcs17-p1-16-02
◽
2018
◽
Author(s):
RK Tahara
◽
T Fujii
◽
B Saigal
◽
NK Ibrahim
◽
S Damodaran
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Hormonal Therapy
◽
Hormone Receptor
◽
Phase Ii Study
◽
Hormone Receptor Positive
◽
Radium 223
◽
Positive Breast Cancer
Download Full-text
Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer
British Journal of Cancer
◽
10.1038/bjc.2015.247
◽
2015
◽
Vol 113
(4)
◽
pp. 585-594
◽
Cited By ~ 12
Author(s):
Nathalie Quenel-Tueux
◽
Marc Debled
◽
Justine Rudewicz
◽
Gaetan MacGrogan
◽
Marina Pulido
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Hormone Receptor
◽
Phase Ii Study
◽
Locally Advanced
◽
Genomic Analysis
◽
Hormone Receptor Positive
◽
Positive Breast Cancer
Download Full-text
Randomised Phase II Study of Palbociclib Plus Exemestane with GnRH Agonist Versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer
SSRN Electronic Journal
◽
10.2139/ssrn.3414442
◽
2019
◽
Author(s):
Yeon Hee Park
◽
Tae-Yong Kim
◽
Gun Min Kim
◽
Kyung Hae Jung
◽
Seok Yun Kang
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Gnrh Agonist
◽
Hormone Receptor
◽
Phase Ii Study
◽
Metastatic Breast
◽
Premenopausal Women
◽
Hormone Receptor Positive
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close